Abstract:Background and purpose:Transcriptional silencing by promoter methylation is now believed to be an important mechanism of carcinogenesis. High frequency of promoter methylation of hMLH1, E-cadherin, and p16INK4a gene is detected in various tumours. This study was to detect the methylation pattern of hMLH1, E-cadherin and p16INK4a gene in esophageal squamous cell carcinoma and explore the role of these epigenetic changes in tumorigenesis. Methods:The frozen tumor specimens and matched normal mucosal tissue specimens from 105 patients with esophageal squamous carcinoma were used for the extraction of DNA by phenol-chloroform method. Methylation changes in the promoter region of hMLH1,E-cadherin, and p16INK4a genes were determined by using methylation-specific PCR (MSP). Immunohistochemical staining of hMLH1, E-cadherin, and p16INK4a protein was performed by using EnVision two-step method in the tumor tissues. Results:The positive rates of genes promoter hypermethylation of E-cadherin, hMLH1, and p16INK4a were 57.1% (60/105), 20.9% (22/105) and 50.5% (53/105) in tumor tissues, as compared to 10.5% (11/105), 1.9% (2/105) and 7.6% (8/105) in normal mucosal tissue, respectively. The positive rates were signifi cantly higher in tumor tissues than in normal mucosal tissue for each of the three genes. The absence rates of protein expression of E-cadherin, hMLH1, andp16INK4a were 48.6% (51/105), 21.9% (23/105) and 71.4% (75/105) respectively. Promoter hypermethylation of E-cadherin (P=0.021) or p16INK4a (P=0.026) gene was remarkably associated with the loss of protein. hMLH1 promoter hypermethylation was not signif icantly correlated with the loss of protein. ESCC with E-cadherin gene promoter hypermethylation was signifi cantly correlated with lymph node metastasis (P=0.016), p16INK4a gene promoter hypermethylation was found more in poorly-differentiated squamous cell carcinoma (P=0.024), hMLH1 promoter hypermethylation was not associated with any of the clinicopathological features. Conclusion:P16INK4a promoter hypermethylation was associated with loss of protein and poor differentiation, which might be involved in the tumorigenic process of ESCC. E-cadherin promoter hypermethylation was correlated with expression deletion and lymph node metastasis, which may play a significant role in pathogenesis of ESCC. hMLH1 promoter hypermethylation might not be involved in tumorigenesis of ESCC.

The Hypermethylation of the CDKN2A and CHFR Promoter Region is a Key Regulatory Mechanism of CDKN2A and CHFR Expression in Esophageal Squamous Cell Carcinoma

Hypermethylation-modulated Down-Regulation of CDH1 Expression Contributes to the Progression of Esophageal Cancer.

Methylation of CHFR Sensitizes Esophageal Squamous Cell Cancer to Docetaxel and Paclitaxel

CHFR Promoter Hypermethylation is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process

Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.

Hypermethylation of DICKKOPF-3 gene and aberrant expression of cyclin D1 in esophageal squamous cell cancer

Promoter methylation and its significance of hMLH1, E-cadherin and p16INK4a gone in esophageal squamous cell carcinoma

Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma

The Hypermethylation of Muc2 Promoter Associated with Mrna and Metastasis in Esophageal Squamous Cell Carcinoma

H3K27 Trimethylation and H3K9 Dimethylation As Poor Prognostic Markers for Patients with Esophageal Squamous Cell Carcinoma.

Dna Methylation Status Of Pax1 And Znf582 In Esophageal Squamous Cell Carcinoma

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated with Better Patient Outcome

Aberrant Hypermethylation of RASSF2 in Tumors and Peripheral Blood DNA As a Biomarker for Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma.

Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling

Promoter Methylation-Associated Silencing Of P27kip1 Gene With Metastasis In Esophageal Squamous Cell Carcinoma

Role of Aberrant Promoter Hypermethylation of the CHFR Gene in the Clinical Significance of Esophageal Cancer

Secretoglobin-3A1 Gene Promoter Hypermethylation Relevant to Esophageal Squamous Cell Carcinoma

Aberrant DNA Methylation of P16, MGMT, and Hmlh1 Genes in Combination with MTHFR C677T Genetic Polymorphism in Esophageal Squamous Cell Carcinoma.

Promoter Methylation and Protein Expression of Apoptosis Protease Activating Factor-1 Gene in Esophageal Squamous Cell Carcinoma

The Detective, Prognostic, and Predictive Value of DNA Methylation in Human Esophageal Squamous Cell Carcinoma

Promoter Hypermethylation of the RUNX3 Gene in Esophageal Squamous Cell Carcinoma